Insulet Corporation

Insulet Corporation

$268.77
2.28 (0.86%)
NASDAQ Global Select
USD, US
Medical - Devices

PODD Price Chart

Basic
Market Cap$16.66B
Price$268.77
52 Week Range160.19-279.4
Beta1.22
Margins
Gross Profit Margin76.27%
Operating Profit Margin17.84%
Net Profit Margin23.22%
Valuation (TTM)
P/E Ratio44.82
Price to Sales Ratio10.41
Price to Book Ratio16.87
PEG Ratio6.38

Industry

Medical - Devices

Sector

Healthcare

Full-Time Employees

3,000

IPO Date

2007-05-15T00:00:00.000Z

Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Phone

978 600 7000

Address

100 Nagog Park, Acton, MA, 01720, US

CIK

0001145197